Cite
HARVARD Citation
Outtier, A. et al. (2021). Effect of vedolizumab dose intensification on serum drug concentrations and regain of response in inflammatory bowel disease patients with secondary loss of response. GastroHep. 3 (2), pp. 63-71. [Online].